BIDU enters the week with a striking divergence: the lending pool has nearly dried up even as options traders remain relatively relaxed, creating an unusual tension in positioning that merits attention.
The borrow story is the week's standout. Availability collapsed from roughly 99% on July 3 to just 6% on July 7 — the tightest reading in the past 52 weeks — meaning almost every share in the lending pool is now out on loan. That move happened in two days. Short interest has been climbing steadily too, rising about 3% week-on-week to just under 9 million shares, and up 7% over the past month. Cost to borrow, while still low in absolute terms at 0.95%, has jumped 38% in a week and nearly 70% over the past month — a signal that demand for borrows is outpacing available supply. The short score has moved with it, ticking up from 52 to 55.5 over the past week, and reaching 58 as recently as June 24. The setup looks increasingly constrained for anyone trying to establish a new short position.
Options positioning tells a quieter story. The put/call ratio at 0.52 is running a fraction below its 20-day average of 0.55, placing it modestly on the call-heavy side — the opposite of what you'd expect if the equity market were pricing in significant downside. That's a contrast worth naming: while the lending market is behaving as if short demand is surging, options traders show no corresponding defensive rotation. The PCR has actually drifted lower since mid-June, when it was closer to 0.61, suggesting equity hedging has eased even as borrowing costs have tightened.
The Street remains mixed on Baidu, though with a slight constructive tilt. The most recent analyst move was Susquehanna lifting its target to $140 from $120 in late May, maintaining Neutral — a modest acknowledgment of improvement after the Q1 print, without conviction. Benchmark holds a $215 Buy, while Barclays sits at Equal-Weight with a $128 target, cut from $147 in March. The mean price target of around $140 implies meaningful upside from the current $112 level, but the wide dispersion between the $128 floor and $215 high-end reflects deep uncertainty. Factor scores add nuance: forward EPS estimates rank in the 98th percentile year-over-year, and analyst recommendation divergence ranks in the 94th percentile — a sign the bull-bear debate is more polarised than usual. The bear case centres on core advertising revenue declining 15% year-over-year as generative AI cannibalises traditional search load; the bull case rests on AI Cloud growing 34% in the first half of 2025, with AI-native marketing revenue up sharply. Valuation is undemanding at 13.3x trailing earnings and 0.85x book — but cheap doesn't resolve the monetisation question.
Institutional holders are broadly stable. BlackRock added roughly 218,000 shares in the period to June 30, while Capital Research added just over 1 million shares — both modest additions that reflect passive and index-driven flows rather than strong active conviction. Morgan Stanley Investment Management reported a notable increase of nearly 3.8 million shares to March 31, but the gap in reporting dates makes it hard to read that as a current signal. Founder Yanhong Li remains the dominant holder at nearly 20% of shares.
The earnings clock is ticking — the next report is scheduled for August 21. The prior two prints produced a +1.7% one-day move in May 2026, followed by a -6.3% drift over five days, and a -6.2% one-day drop in February. With availability at its tightest in a year and short interest still climbing, the August print will be worth watching not just for the revenue trajectory on AI monetisation, but for whether the borrow squeeze resolves before or after the catalyst.
See the live data behind this article on ORTEX.
Open BIDU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
